Azenta, Inc. (AZTA)
Healthcare • Medical Instruments & Supplies
StockNasdaqGSUnited StatesUS1143401024
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Azenta, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 16:55. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 10 Nov 2026 16:00 | 0.11 | 0.28 | +150.7% | Beat |
| 04 Aug 2026 16:00 | 0.10 | 0.16 | +60.0% | Beat |
| 05 May 2026 16:00 | 0.14 | -0.04 | -129.0% | Miss |
| 04 Feb 2026 06:00 | 0.13 | 0.09 | -33.0% | Miss |
| 21 Nov 2025 06:00 | 0.20 | 0.21 | +7.3% | Beat |
| 05 Aug 2025 06:00 | 0.14 | 0.19 | +39.0% | Beat |
| 07 May 2025 06:00 | 0.07 | 0.05 | -31.8% | Miss |
| 05 Feb 2025 07:00 | 0.06 | 0.08 | +33.3% | Beat |
| 12 Nov 2024 16:00 | 0.11 | 0.18 | +61.2% | Beat |
| 06 Aug 2024 16:00 | 0.07 | 0.16 | +134.2% | Beat |
| 08 May 2024 16:00 | 0.02 | 0.05 | +172.8% | Beat |
| 07 Feb 2024 16:00 | -0.03 | 0.02 | +158.8% | Beat |
| 13 Nov 2023 16:00 | 0.02 | 0.13 | +609.2% | Beat |
| 08 Aug 2023 16:00 | -0.02 | 0.13 | +699.9% | Beat |
| 09 May 2023 16:00 | -0.02 | -0.06 | -172.7% | Miss |
| 08 Feb 2023 16:00 | 0.10 | 0.12 | +20.0% | Beat |
| 14 Nov 2022 16:00 | 0.07 | 0.16 | +142.4% | Beat |
| 09 Aug 2022 16:00 | 0.09 | 0.12 | +37.1% | Beat |
| 09 May 2022 16:00 | 0.11 | 0.12 | +7.5% | Beat |
| 08 Feb 2022 16:00 | 0.08 | 0.12 | +54.8% | Beat |
| 10 Nov 2021 16:00 | 0.77 | 0.78 | +1.9% | Beat |
| 05 Aug 2021 16:00 | 0.69 | 0.72 | +4.5% | Beat |
| 10 May 2021 16:00 | 0.51 | 0.61 | +20.8% | Beat |
| 02 Feb 2021 16:00 | 0.42 | 0.47 | +12.3% | Beat |
| 10 Nov 2020 16:00 | 0.36 | 0.47 | +31.9% | Beat |
| 30 Jul 2020 16:00 | 0.20 | 0.32 | +61.3% | Beat |
| 30 Apr 2020 17:00 | 0.25 | 0.25 | -1.8% | Miss |
| 06 Feb 2020 16:00 | 0.24 | 0.23 | -2.4% | Miss |
| 06 Nov 2019 16:00 | 0.23 | 0.24 | +4.3% | Beat |
| 01 Aug 2019 16:00 | 0.16 | 0.20 | +22.3% | Beat |
| 29 Apr 2019 16:00 | 0.10 | 0.17 | +70.7% | Beat |
| 05 Feb 2019 16:00 | 0.13 | 0.17 | +28.9% | Beat |
| 19 Nov 2018 16:00 | 0.38 | 0.40 | +4.8% | Beat |
| 06 Aug 2018 16:00 | 0.43 | 0.46 | +7.0% | Beat |
| 01 May 2018 16:00 | 0.36 | 0.40 | +12.0% | Beat |
| 01 Feb 2018 16:00 | 0.29 | 0.32 | +10.2% | Beat |
| 09 Nov 2017 07:00 | 0.29 | 0.35 | +19.9% | Beat |
| 02 Aug 2017 16:00 | 0.30 | 0.36 | +20.7% | Beat |
| 27 Apr 2017 16:00 | 0.25 | 0.28 | +10.0% | Beat |
| 01 Feb 2017 16:00 | 0.20 | 0.25 | +23.4% | Beat |
| 10 Nov 2016 07:00 | 0.15 | 0.22 | +42.5% | Beat |
| 28 Jul 2016 16:00 | 0.13 | 0.16 | +27.0% | Beat |
| 28 Apr 2016 16:00 | 0.04 | 0.07 | +75.0% | Beat |
| 03 Feb 2016 16:00 | — | 0.02 | +545.4% | Beat |
| 05 Nov 2015 16:00 | 0.13 | 0.17 | +31.4% | Beat |
| 06 Aug 2015 16:00 | 0.10 | 0.15 | +48.0% | Beat |
| 30 Apr 2015 16:00 | 0.06 | 0.08 | +44.8% | Beat |
| 05 Feb 2015 16:00 | 0.06 | 0.05 | -11.5% | Miss |
| 12 Nov 2014 16:00 | 0.06 | 0.07 | +13.2% | Beat |
| 31 Jul 2014 16:00 | 0.04 | 0.05 | +20.5% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 593.8M | +3.6% | -55.8M | -9.4% | -1.30 | +63.9% | 38.3M |
| 2024 | 573.4M | +4.0% | -164.9M | -28.8% | -3.60 | -1,537.5% | 12.4M |
| 2023 | 551.5M | -0.7% | -14.6M | -2.7% | -0.22 | -100.8% | -33.6M |
| 2022 | 555.5M | — | 2.1B | 384.0% | 28.48 | — | -543.5M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 39.18 | 50.06 | 35.05 | 43.57 | +11.55% | 9,688,569 | |
| Oct 2026 | 34.92 | 46.41 | 33.03 | 39.06 | +11.95% | 27,054,800 | |
| Sep 2026 | 32.56 | 35.24 | 29.64 | 34.89 | +6.86% | 18,515,200 | |
| Aug 2026 | 27.76 | 37.49 | 27.76 | 32.65 | +16.07% | 15,950,500 | |
| Jul 2026 | 25.52 | 29.04 | 24.25 | 28.13 | +10.23% | 13,085,600 | |
| Jun 2026 | 22.55 | 25.84 | 21.77 | 25.52 | +11.54% | 18,358,800 | |
| May 2026 | 24.65 | 25.60 | 15.93 | 22.88 | -6.88% | 33,329,500 | |
| Apr 2026 | 21.27 | 27.68 | 20.39 | 24.57 | +16.28% | 17,975,700 | |
| Mar 2026 | 26.26 | 26.55 | 19.87 | 21.13 | -21.68% | 22,737,000 | |
| Feb 2026 | 38.48 | 39.04 | 26.75 | 26.98 | -30.61% | 17,989,100 | |
| 51 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Azenta Inc (AZTA) (Q4 2026) Earnings Call Highlights: Revenue Tops Guidance as Gene Synthesis ... (opens in a new tab) GuruFocus.com · 11 Nov 2026 21:07
- Azenta (AZTA) Q4 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 11 Nov 2026 19:30
- What Azenta (AZTA) Said on Its Q4 Earnings Call (opens in a new tab) MarketBeat · 11 Nov 2026 17:15
- Azenta, Inc. Q4 2026 Earnings Call Summary (opens in a new tab) Moby · 11 Nov 2026 13:30
- Azenta, Inc. (AZTA) Q4 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 11 Nov 2026 11:29
- Azenta, Inc. 2026 Q4 - Results - Earnings Call Presentation (opens in a new tab) SeekingAlpha · 11 Nov 2026 09:02
- Azenta (NASDAQ:AZTA) Q4 Earnings Beat Revenue and EPS Consensus, Shares Rise After Hours (opens in a new tab) ChartMill · 10 Nov 2026 23:05
- Azenta (NASDAQ:AZTA) reports upbeat Q3 CY2026, stock jumps 10.3% (opens in a new tab) StockStory · 10 Nov 2026 21:50
- Azenta Reports Fourth Quarter and Full Year Results for Fiscal 2026, Ended September 30, 2026. (opens in a new tab) 10 Nov 2026 21:30
- Azenta Sees FY2027 Sales $648.000M-$660.000M vs $639.051M Est (opens in a new tab) Benzinga · 10 Nov 2026 17:31
- Azenta Q4 Adj. EPS $0.28 Beats $0.11 Estimate, Sales $167.088M Beat $160.133M Estimate (opens in a new tab) Benzinga · 10 Nov 2026 17:31
- Azenta: A Sample Custody Annuity Priced Like A Broken Equipment Vendor (opens in a new tab) SeekingAlpha · 03 Nov 2026 12:30
- Azenta Stock Outlook After DNA Technology Deal (opens in a new tab) Simply Wall St. · 01 Nov 2026 08:17
- Moderna, Progyny, Azenta, Oscar Health, and agilon health Shares Skyrocket, What You Need To Know (opens in a new tab) StockStory · 19 Oct 2026 23:00
- Azenta (AZTA) Could Be 14% Below Fair Value Following Margin Expansion Narrative (opens in a new tab) Simply Wall St. · 18 Oct 2026 11:18
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 43.86 USD
- Market cap
- 1.8B
- 5-year average yield
- 0.52%
- Last dividend
- 0.1000 USD · 02 Dec 2021
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Currency
- USD
Dividends
| Ex-dividend date | Per share |
|---|---|
| 02 Dec 2021 | 0.1000 USD |
| 02 Sep 2021 | 0.1000 USD |
| 03 Jun 2021 | 0.1000 USD |
| 04 Mar 2021 | 0.1000 USD |
| 8 older dividends: create a free account to see them | |
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Business growth Yearly growth of revenue and of earnings per share. | 3.7 / 25 |
|
| Quality Return on equity, net margin and how stable the margins are. | 0.0 / 25 |
|
| Financial strength Net debt against operating earnings, interest cover and free cash flow. | 20.0 / 20 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 4.5 / 15 |
|
| Analysts How far the analysts' average target is from today's price. | 0.0 / 10 |
|
- The last full year was a loss
Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A). Warnings take 6 points off.
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio. How the score works
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (forward) | 76.96× | Weak | 14.16× |
| Price / book | 1.17× | Good | 3.5× |
| Price / sales | 2.89× | Fair | 3.33× |
| EV / EBITDA | 45.49× | Weak | 11.19× |
| Free cash flow yield | 3.6% | Fair | 2.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 44% | Good | 54.9% |
| Operating margin | -2.3% | Weak | 5.8% |
| Net margin | -20% | Weak | 1.2% |
| Return on equity | -7% | Weak | 4.4% |
| Return on assets | -0.7% | Weak | 2.7% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | 2.2% | Weak | 10.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 0.04× | Good | 0.4× |
| Net debt / EBITDA | -8.24× | Good | 1.46× |
| Current ratio | 2.5× | Good | 2.64× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 0% | Weak | 0% |
| Dividend growth / year | 2.5% | Fair | 6.5% |
| Years of rising dividends | 0 | Weak | 1.5 |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Similar shares
Follow AZTA and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.